Unique ID issued by UMIN | UMIN000013553 |
---|---|
Receipt number | R000014416 |
Scientific Title | The feasibility study of transcranial magnetic stimulation for resistant major depressive episode |
Date of disclosure of the study information | 2014/04/01 |
Last modified on | 2018/06/18 11:19:51 |
The feasibility study of transcranial magnetic stimulation for resistant major depressive episode
The feasibility study of transcranial magnetic stimulation for resistant major depressive episode
The feasibility study of transcranial magnetic stimulation for resistant major depressive episode
The feasibility study of transcranial magnetic stimulation for resistant major depressive episode
Japan |
major depressive disorder,
bipolar disorder
Psychiatry |
Others
NO
To examine the feasibility and preliminary efficacy of transcranial magnetic stimulation for resistant major depressive episode
Others
Feasibility
Exploratory
Explanatory
Not applicable
Adherence to treatment
1)Beck Depression Inventry II(BDI-II)
2)Hamilton Depression Rating Scale (Ham-D) 17items
3)Montgomery Asberg Depression Scale (MADRS)
4)Frequency,Intensity, and Burden of Side Effects Rating (FIBSER)
5)Young Manic Rating Scale (YMRS)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Low-frequency rTMS to the right dorsolateral prefrontal cortex
or
High-frequency rTMS to the left dorsolateral prefrontal cortex
20 | years-old | <= |
Not applicable |
Male and Female
1)DSM-IV-TR diagnosis of major depressive disorder (MDD) or bipolar disorder (BD)
2)Hamilton Scale for Depression 17-item score: 14 or more
3)Medication resistance(Insufficient clinical improvement of MDD from at least two antidepressant trials/ Insufficient clinical improvement of BD from lithium or lamotrigine and atypical antipsychotic treatment )
4)Capability of informed consent
5)Aged 20 years old or more
1)Other Axis I disorders
2)Axis II disorders
3)Seizure-inducing disease (brain tumor, head injury, etc.)
4)Neurologic disorder, organic brain disorder
5)History of seizure
6)Paroxysmal EEG abnormality
7)Pregnancy
8)Ferromagnetic material in head(except oral cavity)
9)Patients with a pacemaker
10)Active suicide idea
11)Stupor state
12)Previous treatment with electroconvulsive therapy within one month
13)Depressive patients related to physical diseases or drugs
14)Family members of researchers
15)Patients likely to change to another hospital within 6 months
16)Patients judged to be not appropriate for participation in this study by the physician
17) Patients who do not understand Japanese
20
1st name | |
Middle name | |
Last name | Seishi Terada |
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Department of Neuropsychiatry
2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
086-235-7246
terada@cc.okayama-u.ac.jp
1st name | |
Middle name | |
Last name | Masatoshi Inagaki |
Okayama University Hospital
Department of Neuropsychiatry
2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
086-235-7246
masatoshiinagaki@med.okayama-u.ac.jp
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science
Okayama University
Other
Okayama Psychiatric Medical Center
NO
2014 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2013 | Year | 11 | Month | 19 | Day |
2014 | Year | 04 | Month | 01 | Day |
2014 | Year | 03 | Month | 28 | Day |
2018 | Year | 06 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014416